STAT3 and diabetic kidney disease: In a mouse model of diabetic kidney disease (the most common form of human chronic kidney disease), mice that are heterozygous for a STAT3 loss of function mutation have reduced interstitial fibrosis and inflammation, and improved renal function compared to diabetic mice with wild-type STAT3 [47].